This review reports that exosome-based therapies, coupled with nanotechnology and AI, show promise in aesthetic medicine, notably in skin rejuvenation and hair restoration, but large-scale trials and clearer regulatory frameworks are needed for effective clinical adoption.
June 2025 in “Journal of Education Health and Sport” This review discusses the role of JAK inhibitors in treating alopecia areata by targeting the JAK/STAT pathway and highlights the promising results but also ongoing challenges such as relapse risk and side effects.
May 2025 in “Universidad Industrial de Santander” This study outlines a business plan for a natural hair tonic containing minoxidil and natural oils, addressing market demand for effective, eco-friendly hair growth products, with strategies focused on digital sales and sustainable packaging.
April 2025 in “Journal of Skin and Stem Cell” This review discusses the potential of polydeoxyribonucleotide (PDRN) for various dermatological treatments and highlights its significant effects on wound healing, anti-aging, acne scars, and hair loss, but emphasizes the need for further clinical studies.
March 2025 in “Journal of Neonatal Surgery” This survey paper analyzes advancements in robotic surgery, highlighting the integration of autonomous systems in medical practices and their impact on precision and patient outcomes, while discussing benefits, challenges, and ethical considerations, with a focus on applications from neonatal to neurosurgical procedures.
March 2025 in “Journal of the American Academy of Dermatology” Discount pharmacies offer cheaper options for hair loss medications than traditional or direct-to-consumer pharmacies.
March 2025 in “Dermatology Online Journal” This commentary highlights that transgender patients are often dissatisfied with standard hormone replacement therapy for hair-related goals, emphasizing the need for dermatologists to provide informed guidance and tailor treatments.
This review explores how technologies like telemedicine, wearable devices, bioengineering, and digital therapeutics are enhancing the management of sexual dysfunction in patients with chronic diseases by offering personalized and accessible solutions, although traditional approaches often fall short.
March 2025 in “Journal of Burn Care & Research” In this study, the hemostatic net was associated with 100% integration of non-meshed partial-thickness skin grafts without seroma or hematoma in treated burn areas after 21 days.
January 2025 in “Pharmaceuticals” This review discusses the potential of peptide-based hydrogels as biomaterials for treating chronic wounds and reports no new clinical findings.
December 2024 in “African Journal of Biomedical Research” This review discusses the potential of 3D bioprinting to revolutionize cosmetic treatments through personalized skin regeneration, facial reconstruction, and anti-aging therapies, while highlighting the current challenges and promising future in the field of cosmetology.
September 2024 in “Indian Journal of Skin Allergy” This review article explores the current use and evidence of stem cell therapy in dermatology, detailing its applications, benefits, and limitations across various skin disorders, while also addressing teledermatology's rise during COVID-19 and proposing its ongoing integration into healthcare delivery.
July 2024 in “Journal of Investigative Dermatology” This study examined the market trends for biologics that have lost patent exclusivity and predicted that drugs like adalimumab, once facing competition, could see price reductions and decreased market share, although the impact on accessibility and total patient use remains unclear.
July 2024 in “Journal of Cosmetic Dermatology” This article highlights that fractionated laser therapy is gaining attention as a minimally invasive and effective treatment for androgenetic alopecia, offering a potential solution to traditional treatments' limitations.
May 2024 in “Psychiatric News” In this study, analysis of electronic health records suggested that patients taking semaglutide were significantly less likely to experience suicidal ideation compared to those on non-GLP-1 obesity or diabetes medications.
May 2024 in “IntechOpen eBooks” In this study, the authors explored the efficacy of hyperbaric oxygen therapy for typical sports injuries and cosmetic surgical wounds, finding that a hormetic dose-response relationship could explain the observed successes, contrary to prevailing expert opinion that deemed this treatment ineffective for normal wounds.
April 2024 in “Pharmaceuticals” This review highlights the clinical usefulness of bimatoprost in lowering intraocular pressure for glaucoma patients and its promising results in promoting hair growth for conditions like alopecia, with research also exploring potential new applications and delivery systems.
April 2024 in “Cosmetics” In this review, the authors explore how wigs can significantly improve the quality of life for individuals with alopecia areata by providing emotional benefits and serving as a coping mechanism for hair loss, while also addressing economic considerations and potential barriers to their use.
April 2024 in “Indian Journal of Paediatric Dermatology” This study in Singapore found that alopecia areata generally does not significantly impact the quality of life for pediatric patients and their families, with better outcomes observed in those with comorbidities like allergic rhinitis.
January 2024 in “Revista da Associação Médica Brasileira” Bald men should protect their scalps from the sun to reduce skin cancer risk.
January 2024 in “African Journal of Biomedical Research” This review article explores the use of drug repurposing as a strategy in drug discovery, highlighting its advantages such as quicker development, cost reduction, known safety profiles, and potential for addressing unmet medical needs.
January 2024 in “Wiadomości Lekarskie” This presentation reviews the potential of novel device-based interventions for heart failure treatment, noting that despite advances in drug therapy, many patients still experience significant symptoms. Results of these interventions, which address limitations of medication, are not reported in this abstract.
October 2023 in “Facial Plastic Surgery” This review discusses combining follicular unit excision (FUE) and linear strip excision (LSE) donor harvesting methods to optimize graft yield while minimizing donor depletion, but provides no new clinical results.
October 2023 in “Skin health and disease” This study found that individuals with alopecia areata in the UK, particularly women and those of Asian ethnicity with lower income and severe symptoms, spent a significant portion of their disposable income on managing the condition, highlighting wigs and private dermatology services as primary expenses.
August 2023 in “Journal of Student Research” This paper discusses the non-curable nature of alopecia and explores various treatments, their side effects, cost, and effectiveness, while also examining how diet, COVID-19, and the COVID-19 vaccine may affect the condition.
July 2023 in “Skin health and disease” This study surveyed UK patients who experienced adverse events from Botulinum Toxin for cosmetic purposes, finding 79% reported issues like long-lasting anxiety, and highlighting low awareness of regulatory bodies and reporting structures.
This overview discusses the condition and treatments for alopecia areata, highlighting that the JAK inhibitor baricitinib, recently approved for severe cases, shows unprecedented effectiveness but raises cost and risk debates regarding treatment of this primarily cosmetic autoimmune disorder.
January 2023 in “Hormone and Metabolic Research” This review discusses drug repositioning as a promising strategy for developing treatments for cardiometabolic disorders and reports no new clinical results.
September 2022 in “Journal of Investigative Dermatology” This study found that the Severity of Alopecia Tool score does not predict the quality of life in patients with alopecia areata, suggesting patient-reported outcomes better reflect the impact on life quality.
May 2022 in “Endocrine practice” This case report illustrates that high-dose biotin supplementation can cause false thyroid function test abnormalities in vitro, emphasizing the need to assess biotin intake before testing.